Why is Aurobindo Pharma falling/rising?

As of 04-Jul, Aurobindo Pharma Ltd. is experiencing a price increase, currently at Rs 1,189.40, which reflects a rise of 30.4 points or 2.62%. The stock has shown strong performance today, outperforming its sector by 2.11% and achieving a consecutive gain over the last three days with a total return of 5.02%. Additionally, the stock reached an intraday high of Rs 1,196.8, indicating positive momentum. However, it is noteworthy that the stock's delivery volume has decreased by 40.22% compared to the 5-day average, suggesting a decline in investor participation. Despite a year-to-date return of -10.92%, the company maintains a low debt-to-equity ratio and a reasonable price-to-book value, which contributes to its attractive valuation.
In the broader market context, Aurobindo Pharma's short-term return of +5.75% over the past week contrasts with the Sensex, which has declined by 0.74%. This indicates that the stock is performing well relative to the overall market. While the stock has struggled over the longer term with a -5.13% return over the past year, it has seen a profit increase of 5.3%. The high institutional holdings at 41.57% suggest that knowledgeable investors are backing the stock, which may provide additional confidence to retail investors. Overall, the combination of recent gains, attractive valuation metrics, and institutional support contributes to the stock's upward movement despite some longer-term challenges.